Bone Densitometry. Dr. Tudor H. Hughes M.D., FRCR Department of Radiology University of California School of Medicine San Diego, California

Similar documents
DXA When to order? How to interpret? Dr Nikhil Tandon Department of Endocrinology and Metabolism All India Institute of Medical Sciences New Delhi

chapter Bone Density (Densitometry) RADIOPHARMACY INDICATIONS Radionuclide Localization Quality Control Adult Dose Range Method of Administration

Building Bone Density-Research Issues

Prevalence of Osteoporosis p. 262 Consequences of Osteoporosis p. 263 Risk Factors for Osteoporosis p. 264 Attainment of Peak Bone Density p.

John J. Wolf, DO Family Medicine

Osteoporosis/Fracture Prevention

Guideline for the investigation and management of osteoporosis. for hospitals and General Practice

The Bare Bones of Osteoporosis. Wendy Rosenthal, PharmD

Osteoporosis - New Guidelines. Michelle Glass B.Sc. (Pharm) June 15, 2011

Interpreting DEXA Scan and. the New Fracture Risk. Assessment. Algorithm

AACE/ACE Osteoporosis Treatment Decision Tool

What is Osteoporosis?

Bone Densitometry. Total 30 Maximum CE 14. DXA Scanning (10) 7

My joints ache. What is the difference between osteoporosis and osteoarthritis?

Bone Mass Measurement BONE MASS MEASUREMENT HS-042. Policy Number: HS-042. Original Effective Date: 8/25/2008

Osteoporosis and Lupus. Andrew Ruthberg, MD University Rheumatologists

Bone density scanning and osteoporosis

EXAMINATION CONTENT SPECIFICATIONS ARRT BOARD APPROVED: JANUARY 2017 IMPLEMENTATION DATE: JULY 1, 2017

STRUCTURED EDUCATION REQUIREMENTS IMPLEMENTATION DATE: JULY 1, 2017

1

Breast Cancer and Bone Loss. One in seven women will develop breast cancer during a lifetime

Management of postmenopausal osteoporosis

Objectives. Discuss bone health and the consequences of osteoporosis on patients medical and disability status.

Osteoporosis. When we talk about osteoporosis, we have to be familiar with the constituents of bone and what it is formed of.

Overview. Bone Biology Osteoporosis Osteomalacia Paget s Disease Cases. People Centred Positive Compassion Excellence

Use of DXA / Bone Density in the Care of Your Patients. Brenda Lee Holbert, M.D. Associate Professor Senior Staff Radiologist

Osteoporosis. Treatment of a Silently Developing Disease

The Bone Densitometry Examination

Osteoporosis. Current Trend in Osteoporosis Management for Elderly in HK- Medical Perspective. Old Definition of Osteoporosis

Bone Mineral Densitometry with Dual Energy X-Ray Absorptiometry

New 2010 Osteoporosis Guidelines: What you and your health provider need to know QUESTIONS&ANSWERS

Osteoporosis. Skeletal System

Osteoporosis. World Health Organisation

Dumfries and Galloway. Treatment Protocol for Osteoporosis

CASE 1 WHY IS IT IMPORTANT TO TREAT? FACTS CONCERNS

Horizon Scanning Technology Briefing. Zoledronic Acid (Aclasta) once yearly treatment for postmenopausal. National Horizon Scanning Centre

Osteoporosis: An Overview. Carolyn J. Crandall, MD, MS

Cortical bone After age 40, gradually decreases % yearly, in both men and women Postmenopausally, loss accelerates to 2-3% yearly

Foreword...v Preface...vii Acknowledgments... xi Dedication... xiii Continuing Medical Education... xxv. Chapter 1: Densitometry Techniques...

DXA scanning to diagnose osteoporosis: Do you know what the results mean?

LUMBAR IS IT IMPORTANT? S. Tantawy,, M.D.

Bone Densitometry Pathway

Osteoporosis. Overview

Osteoporosis Management

New Osteoporosis Guidelines: What you and your health provider need to know QUESTION & ANSWER

Download slides:

OSTEOPOROSIS: PREVENTION AND MANAGEMENT

Because the low bone mass and deterioration

Using the FRAX Tool. Osteoporosis Definition

2013 ISCD Official Positions Adult

Update on Osteoporosis 2016

Clinical Study Comparison of QCT and DXA: Osteoporosis Detection Rates in Postmenopausal Women

Bone Densitometry. What is a Bone Density Scan (DXA)? What are some common uses of the procedure?

New Developments in Osteoporosis: Screening, Prevention and Treatment

Osteoporosis: Who, What, When, Why, and How

Module 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment. William D. Leslie, MD MSc FRCPC

Clinical Practice. Presented by: Internist, Endocrinologist

NEW DEVELOPMENTS IN OSTEOPOROSIS: SCREENING, PREVENTION AND TREATMENT

Osteoporosis Agents Drug Class Prior Authorization Protocol

Bone Mineral Density Studies in Adult Populations

Prevention and Treatment of OSTEOPOROSIS 骨質疏鬆的預防與治療

Fragile Bones and how to recognise them. Rod Hughes Consultant physician and rheumatologist St Peter s hospital Chertsey

Vasu Pai FRACS, Nat Board, MCh, M.S

Osteodensitometry in primary and secondary osteoporosis

nogg Guideline for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK

A Patient s Guide to Osteoporosis

Diagnosis and Treatment of Osteoporosis. Department of Endocrinology and Metabolism Ajou University School of Medicine.

BAD TO THE BONE. Peter Jones, Rheumatologist QE Health, Rotorua. GP CME Conference Rotorua, June 2008

Alendronate sodium in the management of osteoporosis

Adina Alazraki, MD, FAAP Assistant Professor, Radiology and Pediatrics Emory University School of Medicine Children s Healthcare of Atlanta

Osteoporosis Update. Case 2. Case 1: Monday morning, 8:15

Men and Osteoporosis So you think that it can t happen to you

Dual-Energy X-Ray Absorptiometry in the Diagnosis of Osteoporosis: A Practical Guide

BREAST CANCER AND BONE HEALTH

Objectives: What is Osteoporosis 10/8/2015. Bone Health/ Osteoporosis: BASICS OF SCREENING, INTERPRETING, AND TREATING

SpongeBone Menopants*

OSTEOPOROSIS IN MEN. Nelson B. Watts, MD OSTEOPOROSIS AND BONE HEALTH SERVICES CINCINNATI, OHIO

BONIVA (ibandronate sodium)

Measuring Bone Mineral Density

Oral Alendronate Vs. Three-Monthly Iv Ibandronate In The Treatment Of Postmenopausal Osteoporosis

4.7 Studies of Quality Holy Cross Hospital Bone Health Early Stage I ER/PR Positive Breast Cancer Patients December 13, 2017

Omnisense: At Least As Good As DXA

Osteoporosis and Bone Health. Heather Schickedanz, MD Geriatric Knowledge Network, 08/10/16

Bisphosphonates. Making intelligent drug choices

Disclosures. Diagnostic Challenges in Osteoporosis: Whom To Treat 9/25/2014

Dumfries and Galloway. Treatment Protocol for Osteoporosis

Clinician s Guide to Prevention and Treatment of Osteoporosis

COURSE OUTLINE - Module I

Osteoporosis and osteoporotic fracture : A silent enemy of elderly people Islam MS

Corporate Medical Policy

Osteoporosis: Are your bones at risk of fracturing? Rachel Wallwork, MD Internal medicine resident Massachusetts General Hospital

InfoSheet Osteoporosis

Major Recommendations Recommendations apply to postmenopausal women and men age 50 and older.

Updates in Osteoporosis. I have no conflicts of interest. What Would You Do? Mrs. C. What s New in Osteoporosis. Page 1

Osteoporosis Treatment Overview. Colton Larson RFUMS October 26, 2018

1/28/2017. Orthopedic Implications Of Osteoporosis Introduction. Orthopedic Implications Of Osteoporosis Introduction

Awareness, Diagnosis, and Management of Osteoporosis in Adults with Developmental Disabilities

Page 1

Nutritional Aspects of Osteoporosis Care and Treatment Cynthia Smith, FNP-BC, RN, MSN, CCD Pars Osteoporosis Clinic, Belpre, Ohio

Prevention of Osteoporotic Hip Fracture

Transcription:

Bone Densitometry Dr. Tudor H. Hughes M.D., FRCR Department of Radiology University of California School of Medicine San Diego, California Interpretation of DEXA

Osteoporosis Osteoporosis is the most common metabolic bone disorder. It has been defined by the National Institutes of Health as an age-related disorder characterized by decreased bone mass and increased susceptibility to fractures in the absence of other recognizable causes of bone loss.

Osteoporosis Risk factors may be superimposed upon either involutional or secondary osteoporosis, including : Smoking Alcohol Poor diet Lack of exercise An early menopause Strong family history Small frame

Osteoporosis The normal rate of bone loss is 2% per year, hence 20-40% of the female bone mass is already lost by the age of 65 years of age, beginning before the menopause and accelerating afterwards

Osteoporosis Osteoporosis progression over 2Y UC Steroids 59F

Osteoporosis Bone mass is the major determinant of bone strength that can be measured by non-invasive techniques, and accounts for 75-85% of this parameter

Osteoporosis Measurement Plain film, Subjective, Radiogrammetry, Osteogram SPA DPA DEXA QCT US MRI

Osteoporosis Measurement Plain film, Subjective, Radiogrammetry, Osteogram SPA DPA DEXA QCT US MRI

Osteoporosis Measurement Plain film, Subjective, Radiogrammetry, Osteogram SPA DPA DEXA QCT US MRI

Osteoporosis Measurement Plain film, Subjective, Radiogrammetry, Osteogram SPA DPA DEXA QCT US MRI

Osteoporosis Measurement Plain film, Subjective, Radiogrammetry, Osteogram SPA DPA DEXA QCT US MRI

DEXA DEXA has very high accuracy (the difference in the measurement from a known standard) and precision (observed deviation of serial measurements with time) both short and long term to within 1% at the hip and spine

DEXA DEXA is at present the most precise measurement of BMD QCT is more sensitive to change

DEXA Interpretation

Bone Density Clinical Information Sheet Circle Correct Responses Name(Label) Sex: M or F Find out as much relevant information as possible (Premenopausal) F (Perimenopausal) (Postmenopausal) On Hormone Replacement Therapy? N Y On other treatment for osteoporosis? N Y See over Previous Surgery: Spine? N Y right Hips? N Y which? Uterus/Ovaries? N Y left Known Osteoarthritis? N Y Previous Scans When? Where? Risk Factors Previous Fractures N Y Where? Family History Osteoporosis N Y Medication Steroids N Y For Epilepsy N Y Which drug? For Thyroid N Y Which drug? Dietary Calcium High Low Cigarette Smoking N Y Known Bowel Disease(diarrhoea) N Y Diagnosis? Other Medical Condition N Y List

Bone densitometry drug sheet Drugs that may cause osteoporosis Find out as much relevant information as possible Corticosteroids Dilantin Diuretics Methotrexate Thyroxine Heparin Depomedroxyprogesterone acetate Gonadotrophin releasing hormone agonists Cyclosporin Drugs to treat osteoporosis HRT: Estrogen (SERMS): Calcitonin: Bisphosphonates: Raloxifene (Evista) (Nasal spray) (Miacalcin) Alendronate (Fosamax) Etidronate (Didronel) Risedronate (Actonel) Ibandronate Pamidronate (Aredia) Others: Combinations, Thiazides, Fluoride, PTH, Growth Hormone, Bicarbonate, Active Vitamin D

Bone Densitometry DEXA spine check list Note the age, sex, ethnicity and weight Does this match the reference ranges? Is the bottom of L4 roughly at the level of the iliac crests Are there any ribs on L1 Scoliosis Are the vertebrae correctly divided Anything in the soft tissue

Vertebroplasty

Calcium Tablets

Transitional vertebrae Wrong levels

Bone Densitometry DEXA spine check list Look for significant level to level variations 15-20% difference between adjacent levels

Bone Densitometry In preventing Fxs it is the worst scenario that matters. Generally a slight increase in density as descend the L spine. Approx 6% increase between L1 and L4.

What s wrong with this scan? Divisions don t account for scoliosis

What s wrong with this scan? Everything

DEXA Femur check list Hints for a good scan. Patient should be straight on table. Pack patient with rice bags. Shaft of femur should be straight. Rotate leg inward, this will hide the lesser trochanter.

DEXA Femur check list Hints for a good scan. The Wards area is roughly half the neck area Trochanteric area 8-14cm 2 in women, 10-16cm 2 in men Check left and right and state side being used in report.

Typical Femur Scan

What s wrong with this scan? Too much shaft

What s wrong with this scan? Insufficient tissue below neck

What s wrong with this scan? Set up for wrong leg

What s wrong with this scan? Includes ischium

Bone Densitometry WHO uses T scores Normal > -1 SD below young adult Osteopenia -1-2.5 SD Osteoporosis <-2.5 SD Established (Manifest) Osteoporosis + Fxs, usually spine, hip, proximal humerus, wrist, rib

007179 - Macro DEXA CLINICAL HISTORY: REFERENCE FILMS: FINDINGS: FEMUR: The bone mineral density is gm/cm aq. Percentage of young normal mean is %. T-Score is. Percentage age-matched mean is % Z-Score is. World Health Organization and National Osteoperosis Foundation Classification is COMMENTS: LUMBAR SPINE: The bone mineral density is gm/cm aq. Percentage of young normal mean is %. T-Score is %. Percentage of age-matched mean is %. Z-Score is. World Health Organization and National Osteoperosis Foundation Classification is COMMENTS: IMPRESSION: Template

Bone Densitometry Never round up figures -1 is osteopenia, -0.99 is normal -2.5 is osteoporosis, -2.49 is osteopenia

Bone Densitometry 44F

Bone Densitometry 44F

Bone Densitometry 44F

Bone Densitometry 44F

Bone Densitometry T score is compared to reference population, 20-45 years, same sex, any race, any weight. Z score is matched for age, sex, weight and ethnicity.

Two possible reasons for this lady s Z score being worse than the T score?

Two possible reasons for this lady s Z score being worse than the T score? Obesity and race

The T score is based on a white, same sex, age 20-40 population. The patient's BMD is compared to this population's BMD. A lower T score means that the patient BMD is low compared to this young, healthy normal weight population. The Z score compares the patient to an adjusted population, it adjusts for age, weight, and ethnic background. The Z score can be lower than the T score for the patient, if the average patient in this population has a higher BMD than the average in the T score population. This can be seen in patients with higher weights, (which increases bone density), and in African American groups, (which show increased bone density). If the patients comparison group has a generally higher bone density, then it is possible to have a poorer comparison to others of same age, than to younger comparisons in generally lower density group.

260 lb man, young Z above young T

Black as Black Black as White

Black as Black > Black as < White T same Z up

Bone Densitometry Weight gain/loss and Z Weight gain (or loss) will not affect Z score comparison, since Z scores are weight matched, but should cause an increase (or decrease) in absolute BMD. An increase in weight, pushes up the reference range, and therefore the Z score may seem reduced, and vice versa. 2.2lbs=1Kg

Bone Densitometry Weight gain/loss and T Weight gain (or loss) should cause an increase (or decrease) in absolute BMD. Weight gain (or loss) will affect T score comparison, since reference range will not have changed. Hence an increase in weight with a corresponding increase in bone density, will look like a good improvement in T score, but fracture risk is unchanged.

51F 90Kg 53F 51Kg

1.176 1.172 SD = 0.1 Both between -2 and -3 SD below mean for age 1Y, 16lb gain, 5% BMD loss = significant increase in fracture risk

Bone Densitometry Comparison with previous Are the studies comparable Always compare like with like Thornton L1-4 4th and Lewis (previously L2-4) Any intervening events Cannot compare Hologic and Lunar

Bone Densitometry Comparison with previous David Sartoris s previous studies that do not mention the region or levels measured, were standardized for L1-4 and the femoral neck. He usually did not quote BMD. Many previous studies were prior to the current database. Use the percent young adult as a guide to percentage change.

Bone Densitometry Comparison with previous If over a period of time there is an increase in BMD in the lower lumbar spine and decrease in the upper lumbar spine, it is likely there is OA of the lower facet joints, and the upper lumbar spine is a truer reflection of useful BMD.

Bone Densitometry Comparison with previous Increase in BMD of the femoral neck can be due to calcar buttressing with OA of the hip.

Bone Densitometry Comparison with previous If you want to eyeball the % for a comparison, use the young adult % since the reference range will not change with age. A static bone density is actually a good result over a significant period of time If a test is 1% precise, then a change has to be greater than 2% to be significant

Bone Densitometry Comparison with previous If you would have expected the bone density to have fallen 4% in 2 years, and it is static, then this is a positive response to RX

Bone Densitometry Comparison with previous Generally Rx affects all levels equally. OA does not.

Bone Densitometry Comparison with previous 55F

Bone Densitometry 55F

Bone Densitometry 55F

Bone Densitometry 55F

Bone mass in healthy children Radiology 1991;179:735-738

Bone mass in healthy children Increases with age, weight and pubertal Tanner stage. Tanner stage and weight are best predictors of bone mass. Age, sex, race, activity and diet are not good predictors, when weight and Tanner stage are controlled. Radiology 1991;179:735-738

Bone mass in healthy children Make sure we have at least the age and weight of the child, if not the Tanner stage. Radiology 1991;179:735-738

BMD in children and adolescents

BMD in children and adolescents BMD in children and adolescents- Female- L2-4- Lunar

BMD in children and adolescents BMD in children and adolescents- Male- L2-4- Lunar

Cases

New Case 6 63F

5 63F

4 63F

3 63F

2 63F

Report Because of the previous laminectomy at L4, which may also be affecting the reading on the inferior aspect of L3, the BMD is averaged at L1-2. Note is also made of mild decrease in the L4 vertebral height. 1 63F

New Case 3 35F White 242lbs 62in

2 35F White 242lbs 62in

Report Because of the patients weight, the T score may not fully represent the fracture risk, and note should be made that the Z score is 1.7 SD below age and weight matched. 1 35F White 242lbs 62in

New Case 2 OGI 39M

Report The very low bone density is compatible with the known diagnosis of osteogenesis imperfecta. 1 39M

New Case 4 46 F

3 Calcified bile 46 F

2 46 F Calcified bile

Report Although the calcified bile is seen on the DEXA scan, it is outside the measured region and will not affect the reading. 1 46 F Calcified bile

New Case Black 2 47F

Report The Z score is worse than the T score at all levels because the the Z score is compared to weight and ethnicity and African American females naturally have a higher bone density than the standard Caucasian used for the T score, even at the age of 47. 1 African American 47F

New Case 2 49F 2Y8M gap Lx spine up, Fem neck down

Report A common cause for the bone density of the lumbar spine to increase whilst that of the femoral neck decreases over time is, the development of lower lumbar spine end plate sclerosis and facet osteophytes. 1 49F 2Y8M gap Lx spine up, Fem neck down

New Case T 2 Sacral agenesis 49F

Report It is likely that only L1 represents close to true bone density and use of femoral neck measurements alone is recommended. 1 Sacral agenesis 49F

New Case 3 Dense R femoral neck 50F

2 50F dense R femoral neck

Report In view of the significant discrepancy between the right femoral neck and lumbar spine measurements, radiographs of the right hip/pelvis are recommended. 1 50F dense R femoral neck

New Case 2d earlier 2d later 3 51F

2 51F Barium in diverticulum from recent enema

Report It was noticed that the patient has had a recent barium study and that barium may therefore falsely elevate the bone density. A repeat study is therfore recommended. 1 51F Barium in diverticulum from recent enema

New Case 53F 51Kg 6 yr later, 8Kg wt loss 47F 59Kg 2

47F 59Kg 53F 51Kg 1

Report As the patient loses weight the T score worsens at a faster rate than the Z score because the reference range for the Z score also is lowered. However with the loss of weight the fracture risk does not increase as much as the T score worsens. 1 6 yr later, 8Kg wt loss

New Case 3 60F

2 60F OA

Report Because of lower lumbar spine degenerative changes the lumbar spine should not be included in the study. 1 60F OA

New Case 3 Rec. repeat 54M ESLD s/p trans

New Case 2 Rec. repeat 54M ESLD s/p trans

Report Only technical error could account for such a finding and therefore repeat study is recommended. 1 54M ESLD s/p trans

New Case 15m earlier 15m later 2 76F response to Rx

Report If all levels increase in bone density over time, it is likely a response to treatment. 1 76F response to Rx

New Case 3 85M Bil THR

2 85M Bil THR

Report When the lumbar spine and hips cannot be used we turn to the distal radius and use the ultradistal measurement. 1 85M Bil THR

New Case 4 DEXA 51F

3 DEXA 51F

2 DEXA 51F

Report Increase in lumbar spine bone density is due to syndesmophytes and ligament ossification. 1 Ank Spond DEXA 51F

New Case 2 59M

Report Calcium anterior to the spine can increase apparent BMD. 1 DEXA pancreatic Cal 59M

New Case 2 50M

Report If the patient does not wish to divulge their personal details, only T score and not Z score can be produced. 1 DEXA no personal data 50M

New Case 4 59F

3 59F

2

Report Benign bone sclerosis such as Worth s disease or Van Buchem s, or a variant of osteopetrosis. Recommend repeat DEXA to check for spurious result. 1 High bone density 8SD 59F

New Case 4 62F

3 62F

MDP 2 62F

Report Benign sclerotic lesion L1 Levels may be incorrect. 1

New Case 76F

76F

Report When a vertebrae collapses, initially it will be of higher density. 1 DEXA L1 fracture 76F

New Case 65F

65F

1Y prior 2m prior DEXA with islet cell met to L2 65F

Report Look out for vertebrae with a different and unaccountable bone density, either higher or lower. 1 DEXA with islet cell met to L2 65F

New Case 44F

44F

Report 5 2, 182lbs 1

New Case 55F

Report 1 55F

55F

Report Good response to Rx 1

1 Report

Bone Densitometry DEPA Gd 153 Accuracy similar to QCT Less radiation than QCT Measures cortical and trabecular Less sensitive to early changes Affected by aortic Ca 2+

Bone Densitometry QCT Single energy 97% accurate Dual energy not routinely available 300mR Fat content adversely affects accuracy Difficult to reproduce positioning Can only measure trabecular bone 8X increase turnover of trabecular bone